Quantcast

Latest Heart failure Stories

2014-03-13 12:29:35

LONDON, March 13, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: MediPoint: Renal Denervation - EU Analysis and Market Forecasts MediPoint: Renal Denervation - EU Analysis and Market Forecasts SummaryNumerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions...

2014-03-12 23:02:34

Collaborative Research Study by Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University of California, San Diego, Shows Blocking microRNA miR-25 Halts Progression of Heart Failure, Improves Cardiac Function, and May Increase Survival New York, NY (PRWEB) March 12, 2014 A team of cardiovascular researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University...

2014-03-12 08:29:57

THE REMEDE SYSTEM RECOGNIZED AS 2014 BEST INNOVATION AT CRT CONFERENCE MINNEAPOLIS, March 12, 2014 /PRNewswire/ -- Respicardia(®), Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the Best Innovation of 2014 from Cardiovascular Research Technologies (CRT) and CV Pipeline for the remed?(®) System, the first and only implantable device for the treatment of central sleep apnea....

2014-03-11 16:26:25

Once Results of Studies Are Approved by the FDA, the Smaller 50cc SynCardia Heart and New Permanent Use Indication Will Triple the Number of Heart Failure Patients Who Can Get a 2nd Chance at Life TUCSON, Ariz., March 11, 2014 /PRNewswire/ -- Recent developments surrounding the SynCardia temporary Total Artificial Heart will make the life-saving device available to three times the number of people suffering from end-stage biventricular heart failure. Over 300 SynCardia Hearts have...

2014-03-07 08:26:22

FRAMINGHAM, Mass., March 7, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Barclays Global Healthcare Conference at 10:15 a.m. EDT on Tuesday, March 11, 2014. The conference is being held March 11-13 at Loews Miami Hotel. A live webcast of...

2014-02-26 16:28:47

FRAMINGHAM, Mass., Feb. 26, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Raymond James 35(th) Annual Institutional Investors Conference at 4:35 p.m. EST on Tuesday, March 4, 2014. The conference is being held March 2-5 at JW Marriott Grande...

2014-02-25 08:32:27

Cardioxyl now evaluating clinical safety and tolerability of improved second-generation HNO prodrug targeting acute decompensated heart failure CHAPEL HILL, N.C., Feb. 25, 2014 /PRNewswire/ -- Cardioxyl Pharmaceuticals, Inc. announced today that the first cohort of patients has been dosed in a Phase I clinical trial of CXL-1427, a novel nitroxyl (HNO) prodrug optimized for clinical development as a potential treatment for acute decompensated heart failure (ADHF). The primary...

2014-02-25 08:32:22

Online Information Helps Consumers Compare Hospital Quality of Care and Prevent Heart Disease RICHMOND, Va., Feb. 25, 2014 /PRNewswire-USNewswire/ -- In celebration of American Heart Month, Virginia Health Information (VHI) has published its Cardiac Care Report. The report lets consumers compare rates of mortality for cardiac patients in Virginia hospitals, 30-day hospital readmissions and how often hospitals provide a variety of cardiac care services. VHI's Cardiac Care Report is a free,...

2014-02-25 08:31:18

Both Needed the SynCardia Total Artificial Heart to Save Their Lives & Help Make Them Stronger for Their Donor Heart Transplants TUCSON, Ariz., Feb. 25, 2014 /PRNewswire/ -- A Newport News, Va., mom and her adult son each had heart problems that started in their early 30s, resulting in the need to receive donor heart transplants in order to live. Because time was of the essence and no donor hearts were available, they each had SynCardia temporary Total Artificial Heart implants to...

2014-02-19 16:24:19

Big Data Solution Identifies 8,500 Patients at Risk for Heart Failure Using Insights from Electronic Medical Records ARMONK, N.Y., Feb. 19, 2014 /PRNewswire/ -- IBM (NYSE: IBM) today announced that Virginia health system Carilion Clinic has identified 8,500 patients at risk for developing heart failure in a pilot project that could lead to early intervention and better care for these patients. (Logo: http://photos.prnewswire.com/prnh/20090416/IBMLOGO ) The pilot was completed in...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related